Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Press Releases Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 494

Anodyne Therapy, LLC Develops New Device For Treatment of Foot and Leg Pain

Advertisement

  Anodyne_Therapy_Trusted

 

Anodyne Therapy, LLC Develops New Device for Treatment of Foot and Leg Pain and

Pledges Donation in Honor of World Diabetes Day

 

TAMPA, FLA., November 6th 2009 -- Anodyne Therapy, the leading innovator in infrared light therapy products announces the launch of their newest product, the Anodyne® Freedom 300 -- designed to allow patients to affordably and effectively treat foot and leg pain in the comfort of their own homes. Utilizing cutting edge technology, the intuitive design of the Anodyne® Freedom 300 allows patients to quickly and correctly apply it for maximum results. In addition, Anodyne Therapy has announced that it will donate the proceeds from the sales of this new product on November 16th (World Diabetes Day is Saturday, November 14th) to two international charities supporting people with diabetes, Wound Care Haiti, and the IFD’s Life For a Child.

The Anodyne® Freedom 300, affordably priced at under $600, is particularly effective for patients whose pain is associated with impaired circulation since it is able to temporarily increase circulation to the feet and legs by more than 100%. "We are ecstatic about our customers' acceptance of our Anodyne® Freedom 300 and their exceptionally positive comments about ease of use and pain reduction," said Craig Turtzo, CEO of Anodyne Therapy. "It is so uplifting to hear how we are improving people’s lives by providing meaningful pain reduction to those who have suffered from long-term pain," he added.

Mr. Turtzo stated, "People with diabetes represent a large portion of our patient base for Anodyne® home units as well as the patients seen in the more than 6,000 healthcare facilities that administer professional Anodyne® Therapy treatments. We would like to offer more to the diabetic community than pain relief. Therefore, we are joining thousands of other supporters of Diabetes Awareness Month and of World Diabetes Day to enhance diabetic awareness and education to reduce diabetic foot complications across the globe."

The International Diabetes Federation (IDF), in its statement issued in October 2009, reported that the number of people with diabetes continues to grow rapidly throughout the world with more than 440 million people estimated to be affected within the next 20 years. During their most recent meeting in Montreal, the IDF stressed prevention of complications associated with diabetes prior to their manifestation.

The recipients of Anodyne Therapy's donation will be two non-profit organizations, a start up NPO, "Wound Care Haiti" and the IDF's "Life for a Child Program." The mission of "Wound Care Haiti" is to establish a limb amputation prevention program in Haiti, by providing preventative foot care, supplies and education to the country's diabetic population. Anodyne Therapy has additionally pledged the donation of two Anodyne® Therapy Professional Systems to aid Wound Care Haiti in their efforts. The IDF's "Life for a Child Program" supports children with diabetes globally by providing appropriate medical supplies and education.
 

Note to Editors: Anodyne Therapy, LLC was formed in 2001 and is a privately held company based in Tampa, Florida. Anodyne Therapy is committed to improving the quality of life of patients through the use of its drug-free and topically applied medical devices. Thirteen published peer reviewed studies document the efficacy of Anodyne® Therapy Professional Systems, and over 6,000 healthcare facilities provide professional treatments to patients. For more information about Anodyne Therapy LLC and its technology, the Anodyne® Therapy Systems, and the Anodyne® Freedom 300, visit www.anodynetherapy.com. For more information about the charities "Wound Care Haiti" and "Life for a Child" visit: http://www.woundcarehaiti.org and http://www.lifeforachild.idf.org/ respectively. For more information about World Diabetes Day visit: http://www.worlddiabetesday.org/.

 

For more information:
Jennifer Turtzo
813-342-4432 xt 127
Jen@anodynetherapy.com

 

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 05 November, 2009 and appeared in  Issue 494

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?